Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms

Leukemia. 2021 Dec;35(12):3573-3577. doi: 10.1038/s41375-021-01300-7. Epub 2021 May 22.

Patrick Harrington^{1

2}, Hugues de Lavallade^{1

2

3}, Katie J Doores⁴, Amy O'Reilly¹, Jeffrey Seow⁴, Carl Graham⁴, Thomas Lechmere⁴, Deepti Radia¹, Richard Dillon^{1

5}, Yogita Shanmugharaj¹, Andreas Espehana¹, Claire Woodley¹, Jamie Saunders¹, Natalia Curto-Garcia¹, Jennifer O'Sullivan¹, Kavita Raj¹, Shahram Kordasti^{1

2}, Michael H Malim⁴, Claire N Harrison^{1

2}, Donal P McLornan^{6

7}

¹ Department of Clinical Haematology, Guy's & St Thomas' NHS Foundation Trust, London, UK.
² School of Cancer and Pharmaceutical Science, King's College London, London, UK.
³ Department of Haematological Medicine, King's College London School of Medicine, London, UK.
⁴ Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
⁵ Department of Medicine and Molecular Genetics, King's College London, London, UK.
⁶ Department of Clinical Haematology, Guy's & St Thomas' NHS Foundation Trust, London, UK. Donal.mclornan@nhs.net.
⁷ School of Cancer and Pharmaceutical Science, King's College London, London, UK. Donal.mclornan@nhs.net.

No abstract available

Publication types